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INTRODUCTION
Heart rate variability (HRV), the variation in the cardiac inter-
beat interval over time, has emerged as a quantitative marker of 
sympathetic and parasympathetic infl  uences on the modulations 
of heart rate,
1) and it has been used to assess autonomic im-
balances. Increased sympathetic or decreased parasympathetic 
nervous system activity predisposes patients with coronary 
heart disease (CHD) to ventricular tachycardia, ventricular 
fibrillation, sudden cardiac death
2,3) and increased mortality.
4) 
Several studies have found that lower HRV is associated with a 
higher risk of coronary heart disease.
5-7) Numerous studies also 
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suggest that lower HRV is associated with traditional risk factors 
of cardiovascular disease
8) such as hypertension,
9,10) diabetes,
11,12) 
high cholesterol,
13, 14) smoking tobacco,
15) being overweight,
16) and 
increasing age.
17,18) 
The Framingham risk score (FRS), which is a global risk 
assessment method comprised of factors including patient age, 
smoking activity, low density lipoprotein cholesterol (LDL) 
levels (or total cholesterol), high density lipoprotein cholesterol 
(HDL) levels, blood pressure (BP), and the presence of diabetes 
mellitus has been accepted as a tool to predict the risk of CHD 
development.
19) Although previous work has mainly focused 
on the relationship between the HRV measures and individual 
established risk factors, little evidence is available about the 
relationship between HRV and the FRS.
18) Therefore, we have 
focused on the relationships between the HRV measures and the 
FRS to confi  rm various HRV indices as predictable tools of future 
risk of CHD development.
METHODS
Subjects included 85 adults (55 men, 30 women, 48 ± 8 
years old) recruited from the Center of Health Promotion at Inje 
University Busan Paik Hospital between November 2009 and 
December 2009. None of the subjects had a medical history of 
any diseases known to aff  ect the autonomic cardiac function such 
as cardiovascular, neurological, or endocrine diseases, and none 
of the subjects were taking medication. The study protocol was 
approved by the Institutional Review Board of the Buan Paik 
Hospital.
All subjects fasted and finished their health check-up prior 
to the assessment of their HRV. Body weight and height were 
measured in subjects clothed in a light gown without shoes; these 
measurements were used to calculate the body mass index (BMI; 
kg/m
2). BP measurements were performed with a standard 
manual sphygmomanometer while participants were in sitting 
position. Antecubital venous blood samples were taken from 
all subjects after a 12-hour overnight fast. The levels of LDL, 
HDL, and fasting glucose were measured using a biochemistry 
autoanalyzer (Toshiba 200-FR; Toshiba, Tokyo, Japan). 
Information about smoking habits and past medical history were 
obtained using a self-administrated questionnaire.
To limit the infl  uence of diurnal and environmental variations, 
the HRV measurements were taken while the patients were in a 
sitting position after resting for 20 minutes. The measurements 
were taken in the morning and at the same room by one trained 
research assistant according to a standardized method. Th  e  HRV 
measurement was taken twice for each subject with a short-
term interval in-between. HRV recordings were obtained in each 
subject using a standard electrocardiogram (ECG) recorder 
implemented in SA6000 (Medicore Co. Ltd, Seoul, Korea). 
From the ECG of each subject, the HRV was extracted with 
an R-peak detection algorithm using differential ECG signals 
after preprocessing procedures, such as low-pass filtering and 
detrending. Recordings were excluded in the event of a failure to 
extract HRV from the ECG due to noise. Recordings with non-
sinus beats that were more than 1% of the total number of beats 
were also excluded. Premature beats and artifacts were carefully 
Table 1. Characteristics of subjects.
Men (n = 55) Women (n = 30)
Framingham risk score 3 (1-5) 2 (1-6)
10 y coronary heart disease risk* 6 (4-9) 2 (1-6)
Mean (ms) 859 (746-976) 855 (789-932)
SDNN (ms) 37 (27-47) 33 (27-50)
RMSSD (ms) 24 (14-38) 28 (20-40)
pNN10 (%) 57 (45-71) 66 (49-75)
pNN20 (%) 28 (14-45) 37 (22-52)
pNN30 (%) 10 (3-26) 17 (8-33)
pNN50 (%) 4 (0.3-13) 4 (1-15)
lnLF (ms
2) 5.9 (5.1-6.3) 5.5 (5.0-6.1)
lnHF (ms
2) 5.2 (4.5-6.3) 5.7 (4.8-6.2)
LF/HF* 1.8 (0.9-2.9) 1.1 (0.7-2.0)
LFnu* 0.6 (0.4-0.7) 0.5 (0.4-0.7)
HFnu* 0.4 (0.3-0.6) 0.5 (0.3-0.6)
Values are presented as median (interquartile range).
SDNN: standard deviation of all normal RR intervals, RMSSD: root 
mean square of successive differences, pNN10, 20, 30, and 50: 
percentage of differences between adjacent RR intervals that are 
greater than 10 ms, 20 ms, 30 ms, and 50 ms respectively, ln: natural 
logarithm, LF: low frequency power, HF: high frequency power, 
LFnu: normalized low frequency power, HFnu: normalized high 
frequency power.  
*P < 0.05 by Mann-Whitney test. Cheol Seung Yoo, et al: HRV and Framingham Risk Score
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eliminated automatically and manually by visual inspection of all 
RR intervals. 
Using the time domain analysis of HRV, the mean length 
of all normal to normal RR intervals (MEAN), the standard 
deviation of all normal to normal R-R intervals (SDNN), the 
square root of the mean squared diff  erences of successive normal 
sinus intervals (RMSSD), and the percentage of successive RR 
interval diff  erences whose absolute value exceeds x ms (pNNx) 
were computed according to standardized procedures.
20,21) In the 
frequency domain analysis, the total power (TP), the very low 
frequency (VLF) spectral power component, the low frequency 
(LF) spectral power component, and the high frequency (HF) 
spectral component were calculated. Th   e TP was defi  ned as the 
total area under the power spectral density (PSD) curve, VLF 
as the power between 0.00 and 0.04 Hz bands, LF as the power 
between 0.04 and 0.15 Hz, and HF as the power between 0.15 
and 0.4 Hz bands under the PSD curve. Th   e LF to HF ratio (LF/
HF) and the normalized LF [LFnu = LF/(TP-VLF) × 100] 
and HF [HFnu = HF/(TP-VLF)] were computed.
22-24) The 
intra-class correlation coefficient for SDNN, RMSSD, pNN10, 
pNN20, pNN30, pNN50, LF, HF, LF/HF, LFnu, and HFnu 
were 0.59, 0.68, 0.84, 0.91, 0.84, 0.77, 0.56, 0.66, 0.76, 0.73, and 
0.66, respectively (P < 0.001).  
The FRS and 10-year risk of CHD development were 
determined by calculating the number of Framingham points 
assigned to each risk factor such as age, LDL, HDL, BP (regardless 
of the use of antihypertensive medications), cigarette smoking, 
and diabetes mellitus (having a diagnosis, fasting glucose ≥ 126 
mg/dL, or hemoglobin A1C > 6.5).
19)
1. Statistical Analyses
As the distribution of HRV parameters and FRS (and 10 
year CHD risk) were skewed, median and interquartile ranges 
were used. A natural logarithmic transformation was applied 
to normalize the distribution of LF and HF.
24) The Spearman 
correlation coefficients between the HRV measures and the 
CHD risk scores (FRS and 10 year CHD risk) were calculated 
for the total population of subjects and for each gender. The 
HRV measures were compared between those with a high 10-
year CHD risk (≥ 10%) and those with a low 10-year CHD 
Table 2. The correlations between HRV and the CHD risk score. 
Overall (n = 85) Men (n = 55) Women (n = 30)
FRS 10 y CHD risk FRS 10 y CHD risk FRS 10 y CHD risk
Mean (ms) 0.08 0.05 -0.06 -0.06 0.35 0.34
SDNN (ms) -0.24* -0.24* -0.42
† -0.41
† 0.03 -0.04
RMSSD (ms) -0.23* -0.27* -0.38
† -0.37
† 0.12 0.04
pNN10 (%) -0.15 -0.21 -0.26 -0.27* 0.07 0.05
pNN20 (%) -0.20 -0.26* -0.28* -0.29* 0.07 0.04
pNN30 (%) -0.25* -0.30* -0.32* -0.33* 0.01 -0.02
pNN50 (%) -0.26* -0.26* -0.30* -0.30* -0.09 -0.09
lnLF (ms
2) -0.29
† -0.24* -0.44
† -0.42
† -0.17 -0.22
lnHF (ms
2) -0.28* -0.31
† -0.40
† -0.39
† -0.03 -0.10
LF/HF 0.05 0.15 0.06 0.09 -0.17 -0.16
LFnu 0.04 0.15 0.05 0.08 -0.17 -0.16
HFnu -0.04 -0.15 -0.05 -0.08 0.17 0.16
HRV: heart rate variability, CHD: coronary heart disease, FRS: Framingham risk score, SDNN: standard deviation of all normal RR intervals, 
RMSSD: root mean square of successive differences, pNN10, 20, 30, and 50: percentage of differences between adjacent RR intervals that 
are greater than 10 ms, 20 ms, 30 ms, and 50 ms respectively, ln: natural logarithm, LF: low frequency power, HF: high frequency power, 
LFnu: normalized low frequency power, HFnu, normalized high frequency power.  
*P < 0.05. 
†P < 0.01.Cheol Seung Yoo, et al: HRV and Framingham Risk Score
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risk (< 10%) using Mann-Whitney test. The predictive ability 
of each HRV measure with respect to higher 10-year CHD risk 
was analyzed using the receiver operating characteristic (ROC) 
curves and logistic regression analyses. ROC curve calculated 
the area under the ROC curve (AUC) to identify higher 10-year 
CHD risk scores. Logistic regression analyses were conducted 
for the z-score of each HRV measure aft  er adjustment for sex and 
BMI. Th   ese analyses were performed using SPSS ver. 17.0 (SPSS 
Inc., Chicago, IL, USA).
RESULTS 
Table 1 shows the characteristics of subjects. Compared to 
women, men had significantly higher 10-year CHD risk, LF to 
HF ratios, LFnu, and lower HFnu. The correlations between 
the FRS and the HRV measures are presented in Table 2. 
Overall, the FRS was signifi  cantly and inversely correlated with 
SDNN, RMSSD, pNN30, pNN50, LF, and HF, although the 
magnitude of the correlations was moderate to weak. When the 
relationships were compared by gender, these signifi  cant inverse 
correlations were found only in men. When the HRV measures 
were compared between those with high 10-year CHD risk and 
those with low 10-year CHD risk, SDNN, RMSSD, and HF were 
significantly lower in those with high 10-year CHD risk (Table 
3). To determine the predictive ability of the HRV measures 
for high 10-year CHD risk, the ROC comparison and logistic 
regression analyses were conducted, and the results are shown 
in Table 4. Th   e RMSSD had the greatest AUC among the HRV 
measures, followed by the AUC of HF, SDNN, LF, LF/HF, and 
Table 4. ROC curve analysis and logistic regression of each heart 
rate variability measure (transformed to z-score) for high (≥ 10%) 
10 y CHD risk. 
ROC curve analysis Logistic regression
†
AUC 95% CI Odds ratio
† 95% CI
Mean (ms) 0.52 0.41-0.63 0.92 0.46-1.85
SDNN (ms) 0.68* 0.57-0.78 0.47* 0.24-0.93
RMSSD (ms) 0.74* 0.63-0.83 0.42* 0.21-0.87
pNN10 (%) 0.62* 0.51-0.72 0.64 0.33-1.24
pNN20 (%) 0.64* 0.53-0.74 0.64 0.33-1.24
pNN30 (%) 0.66* 0.55-0.76 0.58 0.30-1.14
pNN50 (%) 0.64* 0.52-0.74 0.65 0.32-1.31
LF (z-score) 0.67* 0.55-0.67 0.48* 0.24-0.97
HF (z-score) 0.73* 0.63-0.82 0.41* 0.20-0.85
LF/HF 0.66* 0.55-0.76 1.51 0.77-2.99
LFnu 0.66* 0.55-0.76 1.44 0.73-2.83
HFnu 0.66* 0.55-0.76 0.69 0.35-1.36
ROC: receiver operating characteristic, CHD: coronary heart 
disease, AUC: area under the ROC curve, SDNN: standard deviation 
of all normal RR intervals, RMSSD: root mean square of successive 
differences, pNN10, 20, 30, and 50: percentage of differences 
between adjacent RR intervals that are greater than 10 ms, 20 ms, 
30 ms, and 50 ms respectively, ln: natural logarithm, LF: low 
frequency power, HF: high frequency power, LFnu: normalized low 
frequency power, HFnu: normalized high frequency power.  
*P < 0.05. 
†Adjusted for sex and body mass index.
Table 3. Comparison of the HRV measures between high and low 
CHD risk. 
10 y CHD risk < 10% 
(n = 72)
10 y CHD risk ≥ 10% 
(n = 13)
P-value*
Mean (ms) 860 (764-952) 854 (779-956) 0.836
SDNN (ms) 36 (28-49) 28 (19-43) 0.037
RMSSD (ms) 39 (20-46) 28  (19-49) 0.007
pNN10 (%) 61 (48-73) 56 (22-68) 0.179
pNN20 (%) 34 (19-49) 28 (3-39) 0.102
pNN30 (%) 15 (6-29) 10 (0.6-16) 0.062
pNN50 (%) 4 (1-16) 1 (0-8) 0.122
lnLF (ms
2) 5.6 (5.2-6.3) 5.1 (4.5-6.0) 0.060
lnHF (ms
2) 5.5 (4.9-6.3) 4.7 (3.2-5.4) 0.008
LF/HF 1.5 (0.7-2.3) 2.5 (1.3-3.0) 0.067
LFnu 0.4 (0.3-0.6) 0.7 (0.5-0.8) 0.071
HFnu 0.9 (0.6-1.2) 0.3 (0.2-0.5) 0.071
HRV: heart rate variability, CHD: coronary heart disease, FRS: 
Framingham risk score, SDNN: standard deviation of all normal 
RR intervals, RMSSD: root mean square of successive differences, 
pNN10: 20, 30, and 50: percentage of differences between adjacent 
RR intervals that are greater than 10 ms, 20 ms, 30 ms, and 50 ms 
respectively, ln: natural logarithm, LF: low frequency power, HF: 
high frequency power, LFnu: normalized low frequency power, 
HFnu: normalized high frequency power.  
*By Mann-Whitney test. Cheol Seung Yoo, et al: HRV and Framingham Risk Score
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pNN30, which were significant. In logistic regression models 
for high 10-year CHD risk, the odds ratios were significant for 
SDNN, RMSSD, LF, and HF aft  er adjustment for sex and BMI. 
An increase in these valued by one standard deviation att  enuated 
the risk of having a high 10-year CHD risk by 52-59%.
DISCUSSION 
In this study, we found that low HRV measures were 
significantly associated with the FRS, which is comprised 
of traditional CV risk factors. Low HRV measures were also 
associated with the 10-year risk of CHD development. Signifi  cant 
relationships were found for SDNN, RMSSD, LF, and HF 
whether they were applied as continuous or discrete variables. 
In contrast, LF/HF, LFnu, and HFnu were not significantly 
associated with either the FRS or the 10-year risk of CHD 
development. 
The associations between autonomic imbalance and 
coronary arteriosclerosis and its risk factors have been proposed 
and current result is comparable to previous findings.
5,6,18) In 
population-based studies, lower HRV has been associated with 
an increased risk of CHD development. Prior studies also have 
shown a lower vagal tone in individuals with hypertension than in 
healthy individuals.
9,10) A lower vagal tone has also been reported 
in those diagnosed with diabetes compared to those without 
diabetes.
11,12) LDL levels, or total cholesterol, were inversely 
associated with 24-hour HRV
13) or the RMSSD.
14) A low vagal 
tone was also associated with both acute and chronic smoking
15) 
and increasing age.
17) However, the relationship between HRV 
measures and a global risk assessment tool for CHD, such as the 
FRS, has not been clearly documented. 
The SDNN physiologically reflects the parasympathetic 
activity corresponding to fast variations in heart rate and the 
sympathetic activity controlling slow modulation of heart 
function. The RMSSD values are also commonly used HRV 
measures derived from interval diff  erences. All of these measures 
of short-term variation estimate the high-frequency modulation 
in the heart rate, and they are highly correlated.
24) The LF 
component has been proposed as an index of sympathetic 
modulation, whereas HF, which is a measure of respiratory sinus 
arrhythmia, is also used as an index of vagal activity.
22,24) Non-
signifi  cant associations with LF/HF, LFnu, and HFnu could be 
expected because the ratio and proportion measures attenuate 
the information derived from LF and HF, which are signifi  cantly 
associated with the FRS.
5)
Because lower HRV has been indicated as a predictor for the 
development of CHD
5-7) and the FRS is considered an accepted 
assessment tool to estimate the risk of CHD development,
19) 
our findings may confirm HRV as a plausible tool to evaluate 
the future risk of CHD development. However, because 
previous finding regarding the association between lower HRV 
and the development of CHD were significant after adjusting 
for traditional CV risk factors,
5) the causal pathway between 
HRV and the FRS cannot be determined using these data. It 
is likely that reduced HRV may reflect subclinical coronary 
atherosclerosis, and thus it may be a simple marker similar to 
the FRS, which can be used to predict the 10-year risk of CHD 
development. 
In summary, our findings extend previous knowledge, 
confirming that hypoactive parasympathetic activity tends 
to predict a higher 10-year risk of CHD. This study therefore 
indicates that the HRV indices, particularly SDNN, RMSSD, 
pNN30, LF, and HF, may be useful parameters for CHD risk 
assessment. Most notably, the usefulness of these HRV measures 
as indicators for the evaluation of CHD risk may be greater 
among men than among women.
However, some limitations are worth noting. The small 
sample size of women may dampen the statistical power, and 
future studies designed to evaluate gender differences in these 
relationships among a larger sample size of women should 
therefore be conducted.
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